Close Menu

NEW YORK (GenomeWeb) – Courtagen Life Sciences reported today that it has completed the comprehensive Clinical Laboratory Evaluation Program and has received its clinical laboratory permit form the state of New York.

Courtagen — a CLIA/CAP certified company — creates tests for the diagnosis of neurological disorders, primarily using next-generation DNA sequencing, bioinformatics, and clinical interpretation. These tests are designed to help physicians reveal the linkages between the genotypes and phenotypes of various neurological diseases, the company said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that Herbert Tabor, who worked at the US National Institutes of Health for 77 years, has died at 101.

The World Bank is seeking approval for a $12 billion plan to provide low-income nations with funds to procure SARS-CoV-2 vaccines, according to Reuters.

Science writes that public health officials and others are debating whether cycle threshold values should be included on SARS-CoV-2 results.

In Nucleic Acids Research this week: online database of SARS-CoV-2 protein structures, atlas of the human brain, and more.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.